araki kazuhiro 荒木和浩

… Alternative Names

荒木和浩アラキカズヒロ

Less

Researcher Number	80406470
Other IDs	https://orcid.org/0000-0001-7623-7715
Affiliation (Current)	2025: 群馬県衛生環境研究所, 研究企画係, 研究員
Affiliation (based on the past Project Information) *help	2019 – 2023: 群馬県衛生環境研究所, 研究企画係, 研究員 2016 – 2018: 兵庫医科大学, 医学部, 准教授
Review Section/Research Field	Principal Investigator Basic Section 58010:Medical management and medical sociology-related / General surgery
Keywords	Principal Investigator 炎症性サイトカイン / がん薬物療法 / コミュニケーションツール / 患者報告アウトカム / がん治療 / 高齢者医療 / 腫瘍微小環境 / 宿主 / 栄養障害 / 免疫応答 … More / 免疫チェックポイント阻害薬 / 栄養 / 免疫 / 慢性炎症 / 栄養状態 / がん化学療法 / トランスレーショナルリサーチ / 薬剤反応性 / マイクロアレイ / ゲノム / 癌 / Heterogeneity / Genomic alteration / Breast Cancer / HER2 / サイトカイン / 末梢血リンパ球 / 宿主全身状態 / HER2陽性乳癌 / 腫瘍免疫 / 遺伝子変異 / 効果予測因子 / 全エクソソームシーケンス / 原発不明がん / 宿主免疫 / 予測因子 / 悪性腫瘍 / リンパ球 Less

Research Projects
(2 results)
Research Products
(22 results)

Application for liquid biomarker as a medical communication tool in oncology practicePrincipal Investigator
- Principal Investigator
  
  ARAKI KAZUHIRO
- Project Period (FY)
  2019 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 58010:Medical management and medical sociology-related
- Research Institution
  Gunma Institute of Public Health and Environmental Sciences
research of ideal strategy for predictive factor related with genetic alteration resistance of cancer chemotherapy in metastatic advanced breast cancerPrincipal Investigator
- Principal Investigator
  
  araki kazuhiro
- Project Period (FY)
  2016 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  General surgery
- Research Institution
  Gunma Institute of Public Health and Environmental Sciences
  Hyogo Medical University

All 2023 2022 2021 2020 2019 2018 2017

All Journal Article Presentation Book

[Book] 【逸脱症例から学ぶ　がん薬物療法　標準治療の実践!】(第2章)がん合併症マネジメント　脊髄圧迫2019
- Author(s)
  1.荒木　和浩
- Total Pages
  200
- Publisher
  じほう
- ISBN
- Data Source
  KAKENHI-PROJECT-16K10485
[Journal Article] Recurrent Pegfilgrastim-Associated Migratory Large Vessel Vasculitis in a Patient with Breast Cancer with Rare HLA Haplotype: A Case Report2023
- Author(s)
  Araki K1*, Fujisawa T2, Miyamoto T2, Kawakami T3, Anzai H4, Horikoshi H3 and Yanagita Y2
- Journal Title
  
  Annals of Clinical and Medical Case Reports
  
  Volume: V10 Pages: 1-8
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K10569
[Journal Article] Prospective Cohort Study of Combination Therapy With Abemaciclib and Hormonal Therapy for Chemotherapy-Treated Patients With Hormone Receptor-Positive Metastatic Breast Cancer2022
- Author(s)
  Miyahara Kana、Narui Kazutaka、Uemura Yukari、Yamada Akimitsu、Araki Kazuhiro、Fujisawa Fumie、Nakayama Takahiro、Ishikawa Takashi、Taira Naruto、Kikawa Yuichiro、Aihara Tomohiko、Mukai Hirofumi
- Journal Title
  
  World Journal of Oncology
  
  Volume: 13 Issue: 4 Pages: 216-221
- DOI
  10.14740/wjon1511
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K10569
[Journal Article] Health-related quality of life and estimation of the minimally important difference in the Functional Assessment of Cancer Therapy-Endocrine Symptom score in postmenopausal ER+/HER2- metastatic breast cancer with low sensitivity to endocrine therapy2022
- Author(s)
  Kikawa Yuichiro、Hagiwara Yasuhiro、Fujisawa Tomomi、Araki Kazuhiro、Iwamoto Takayuki、Sangai Takafumi、Shien Tadahiko、Takao Shintaro、Nishimura Reiki、Takahashi Masato、Toyama Tatsuya、Aihara Tomohiko、Mukai Hirofumi、Taira Naruto
- Journal Title
  
  PLOS ONE
  
  Volume: 17 Issue: 11 Pages: 0278344-0278344
- DOI
  10.1371/journal.pone.0278344
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K10569
[Journal Article] Good Immunogenicity of Delayed Second Dose of BNT162b2 Vaccine in Individuals with Acute Allergic-Like Reactions after the First Dose2022
- Author(s)
  K. Araki, N. Shimizu, M. Iijima, H. Hosaka and Y. Yanagita
- Journal Title
  
  Reports
  
  Volume: 5 Issue: 4 Pages: 48-53
- DOI
  10.3390/reports5040048
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K10569
[Journal Article] Correction to: Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD)2020
- Author(s)
  Yamashita Toshinari、Masuda Norikazu、Saji Shigehira、Araki Kazuhiro、Ito Yoshinori、Takano Toshimi、Takahashi Masato、Tsurutani Junji、Koizumi Kei、Kitada Masahiro、Kojima Yasuyuki、Sagara Yasuaki、Tada Hiroshi、Iwasa Tsutomu、Kadoya Takayuki、Iwatani Tsuguo、Hasegawa Hiroki、Morita Satoshi、Ohno Shinji
- Journal Title
  
  Trials
  
  Volume: 21 Issue: 1 Pages: 503-503
- DOI
  10.1186/s13063-020-04408-w
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K10569
[Journal Article] Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD)2020
- Author(s)
  Yamashita Toshinari、Masuda Norikazu、Saji Shigehira、Araki Kazuhiro、Ito Yoshinori、Takano Toshimi、Takahashi Masato、Tsurutani Junji、Koizumi Kei、Kitada Masahiro、Kojima Yasuyuki、Sagara Yasuaki、Tada Hiroshi、Iwasa Tsutomu、Kadoya Takayuki、Iwatani Tsuguo、Hasegawa Hiroki、Morita Satoshi、Ohno Shinji
- Journal Title
  
  Trials
  
  Volume: 21 Issue: 1 Pages: 391-391
- DOI
  10.1186/s13063-020-04341-y
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K10569
[Journal Article] The efficacy of sequential second-line endocrine therapies (ETs) in postmenopausal estrogen receptor-positive and HER2-negative metastatic breast cancer patients with lower sensitivity to initial ETs2020
- Author(s)
  Iwamoto Takayuki、Fujisawa Tomomi、Shien Tadahiko、Araki Kazuhiro、Sakamaki Kentaro、Sangai Takafumi、Kikawa Yuichiro、Takao Shintaro、Nishimura Reiki、Takahashi Masato、Aihara Tomohiko、Mukai Hirofumi、Taira Naruto
- Journal Title
  
  Breast Cancer
  
  Volume: － Issue: 5 Pages: 973-981
- DOI
  10.1007/s12282-020-01095-y
- NAID
  120007037397
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K10485, KAKENHI-PROJECT-19K10569
[Journal Article] 進行乳がんに対するオラパリブ2019
- Author(s)
  荒木　和浩, 三木義男
- Journal Title
  
  腫瘍内科
  
  Volume: 23 Pages: 410-419
- NAID
  40021888705
- Data Source
  KAKENHI-PROJECT-16K10485
[Journal Article] Abundant options to avoid toxicity and alternative strategies for human epidermal growth factor receptor 2-positive and hormone receptor-positive advanced breast cancer2018
- Author(s)
  Araki Kazuhiro、Miyoshi Yasuo
- Journal Title
  
  Translational Cancer Research
  
  Volume: 7 Issue: S4 Pages: S514-S518
- DOI
  10.21037/tcr.2018.03.39
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K10485
[Journal Article] Predictive impact of absolute lymphocyte counts for progression-free survival in human epidermal growth factor receptor 2-positive advanced breast cancer treated with pertuzumab and trastuzumab plus eribulin or nab-paclitaxel2018
- Author(s)
  Araki Kazuhiro、Ito Yoshinori、Fukada Ippei、Kobayashi Kokoro、Miyagawa Yoshimasa、Imamura Michiko、Kira Ayako、Takatsuka Yuichi、Egawa Chiyomi、Suwa Hirofumi、Ohno Shinji、Miyoshi Yasuo
- Journal Title
  
  BMC Cancer
  
  Volume: 18 Issue: 1 Pages: 982-988
- DOI
  10.1186/s12885-018-4888-2
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K10485
[Presentation] 化学療法を受ける進行がん患者への高齢者機能評価の導入6ヵ月後の評価2021
- Author(s)
  藤井, 亜弥松本, 弘恵青木, 敏之山本, 和恵長山, 敏子荒木, 和浩
- Organizer
  第59回日本癌治療学会学術集会抄録集
- Data Source
  KAKENHI-PROJECT-19K10569
[Presentation] 進行癌患者の化学療法開始前の高齢者機能評価の導入2020
- Author(s)
  藤井, 亜弥松本, 弘恵青木, 敏之山本, 和恵長山, 敏子荒木, 和浩
- Organizer
  58回日本癌治療学会学術集会抄録集
- Data Source
  KAKENHI-PROJECT-19K10569
[Presentation] 有痛性骨転移に対する緩和的動脈塞栓術の検証的臨床試験(PALEM trial:JIVRSG/JSUPPORT1903)構築の取り組み(第1報)について2020
- Author(s)
  荒井, 保典全田, 貞幹松本, 禎久中村, 直樹高木, 辰哉小林, 英介荒木, 和浩山本, 紘司三枝, 祐輔宮路, 天平小林, 達伺曽根, 美雪内富, 庸介
- Organizer
  Palliative Care Research
- Data Source
  KAKENHI-PROJECT-19K10569
[Presentation] 当院のがんゲノム医療の現状2020
- Author(s)
  荒木, 和浩飯島, 美砂土田, 秀松木, 美紀下山, 富子藤田, 行代志木村, 香宮本, 健志塩原, 一郎保坂, 尚志清水, 信明中村, 和人湊, 浩一鹿沼, 達哉柳田, 康弘
- Organizer
  41日本遺伝カウンセリング学会誌
- Data Source
  KAKENHI-PROJECT-19K10569
[Presentation] 院外患者のがん遺伝子パネル検査を円滑に進めるためのシステム構築2020
- Author(s)
  柳田, 康弘荒木, 和浩宮本, 武志藤澤, 知巳矢内, 恵子飯島, 美砂松木, 美紀
- Organizer
  28回日本乳癌学会総会
- Data Source
  KAKENHI-PROJECT-19K10569
[Presentation] 骨転移疼痛に対する集学的治療　-この痛みをどう治療するか-　有痛性骨転移に対する緩和的動脈塞栓術の臨床経験とEvidence構築への取り組み2020
- Author(s)
  荒井, 保典曽根, 美雪全田, 貞幹山本, 紘司内富, 庸介松本, 禎久高木, 辰哉小林, 英介荒木, 和浩宮路, 天平
- Organizer
  日本インターベンショナルラジオロジー学会雑誌
- Data Source
  KAKENHI-PROJECT-19K10569
[Presentation] がん専門病院における免疫関連有害事象の発現状況とその対策の評価2020
- Author(s)
  新井, 隆広荒木, 和浩長澤, 侑季松本, 弘恵山崎, 美穂藤田, 行代志齊藤, 妙子
- Organizer
  15日本臨床腫瘍薬学会雑誌
- Data Source
  KAKENHI-PROJECT-19K10569
[Presentation] 内分泌療法耐性ER陽性転移乳癌に対する二次内分泌療法のコホート研究　HORSE-BC-研究報告2019
- Author(s)
  藤澤知巳, 平成人, 荒木　和浩, 岩本高行, 木川雄一郎, 坂巻顕太郎, 相原智彦, 高橋將人, 向井博文, 三階貴史, 高尾信太郎
- Organizer
  日本乳癌学会総会, 27回
- Data Source
  KAKENHI-PROJECT-16K10485
[Presentation] 当院のレセプトデータを用いた悪性腫瘍症例の現状の検討2019
- Author(s)
  荒木　和浩
- Organizer
  日本内科学会 108
- Data Source
  KAKENHI-PROJECT-16K10485
[Presentation] 末梢血リンパ球数は抗HER2療法を行う際のHER2陽性進行乳癌の効果予測因子となりえるか2018
- Author(s)
  荒木　和浩
- Organizer
  第26回日本乳癌学会学術総会
- Data Source
  KAKENHI-PROJECT-16K10485
[Presentation] Predictive impact of absolute lymphocyte counts for progression-free survival in HER2-positive advanced breast cancer treated with pertuzumab and trastuzumab plus eribulin or nab-paclitaxel2017
- Author(s)
  Araki, K. Ito, Y. Fukada, I. Kobayashi, K. Ohno, S. Miyagawa, Y. Imamura, M. Kira, A. Takatsuka, Y. Egawa, C. Suwa, H. Miyoshi, Y.
- Organizer
  2017 San Antonio Breast Cancer Symposium
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K10485

araki kazuhiro 荒木 和浩

荒木 和浩 アラキ カズヒロ

Research Projects

Research Products

Application for liquid biomarker as a medical communication tool in oncology practicePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

research of ideal strategy for predictive factor related with genetic alteration resistance of cancer chemotherapy in metastatic advanced breast cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] 【逸脱症例から学ぶ がん薬物療法 標準治療の実践!】(第2章)がん合併症マネジメント 脊髄圧迫2019

Author(s)

Total Pages

Publisher

ISBN

Data Source

[Journal Article] Recurrent Pegfilgrastim-Associated Migratory Large Vessel Vasculitis in a Patient with Breast Cancer with Rare HLA Haplotype: A Case Report2023

Author(s)

Journal Title

Data Source

[Journal Article] Prospective Cohort Study of Combination Therapy With Abemaciclib and Hormonal Therapy for Chemotherapy-Treated Patients With Hormone Receptor-Positive Metastatic Breast Cancer2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Health-related quality of life and estimation of the minimally important difference in the Functional Assessment of Cancer Therapy-Endocrine Symptom score in postmenopausal ER+/HER2- metastatic breast cancer with low sensitivity to endocrine therapy2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Good Immunogenicity of Delayed Second Dose of BNT162b2 Vaccine in Individuals with Acute Allergic-Like Reactions after the First Dose2022

Author(s)

Journal Title

DOI

Data Source

Author(s)

Journal Title

DOI

Data Source

Author(s)

Journal Title

DOI

Data Source

[Journal Article] The efficacy of sequential second-line endocrine therapies (ETs) in postmenopausal estrogen receptor-positive and HER2-negative metastatic breast cancer patients with lower sensitivity to initial ETs2020

Author(s)

Journal Title

DOI

NAID

Data Source

[Journal Article] 進行乳がんに対するオラパリブ2019

Author(s)

Journal Title

NAID

Data Source

[Journal Article] Abundant options to avoid toxicity and alternative strategies for human epidermal growth factor receptor 2-positive and hormone receptor-positive advanced breast cancer2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Predictive impact of absolute lymphocyte counts for progression-free survival in human epidermal growth factor receptor 2-positive advanced breast cancer treated with pertuzumab and trastuzumab plus eribulin or nab-paclitaxel2018

Author(s)

Journal Title

DOI

Data Source

[Presentation] 化学療法を受ける進行がん患者への高齢者機能評価の導入6ヵ月後の評価2021

Author(s)

Organizer

Data Source

[Presentation] 進行癌患者の化学療法開始前の高齢者機能評価の導入2020

Author(s)

Organizer

Data Source

[Presentation] 有痛性骨転移に対する緩和的動脈塞栓術の検証的臨床試験(PALEM trial:JIVRSG/JSUPPORT1903)構築の取り組み(第1報)について2020

Author(s)

araki kazuhiro 荒木和浩

荒木和浩アラキカズヒロ

[Book] 【逸脱症例から学ぶ　がん薬物療法　標準治療の実践!】(第2章)がん合併症マネジメント　脊髄圧迫2019

[Presentation] 骨転移疼痛に対する集学的治療　-この痛みをどう治療するか-　有痛性骨転移に対する緩和的動脈塞栓術の臨床経験とEvidence構築への取り組み2020

[Presentation] 内分泌療法耐性ER陽性転移乳癌に対する二次内分泌療法のコホート研究　HORSE-BC-研究報告2019